Cognivue

02/19/2026

Rethinking how cognitive performance is measured.

Both Cognivue Clarity® and Cognivue Thrive® are powered by adaptive psychophysics—a technology that personalizes testing in real time.

The system:
➡️ Calibrates to an individual’s motor and visual abilities
➡️ Dynamically adjusts task difficulty as performance changes
➡️ Measures cognitive performance across progressively challenging levels

Rather than relying on a static set of questions, the technology continuously adapts to the individual—helping deliver objective, performance-based insights into cognitive function.

Innovation isn’t about adding more questions.
It’s about measuring smarter.

02/12/2026

Rewriting the Concussion Protocol: How Cognivue Enhances Cognitive Evaluation & Recovery Planning

📅 March 5, 2026 | 🕐 1 PM EST/ 10 AM PST

Join us for a special webinar featuring Dr. Jake R. Carpenter-Thompson, MD, PhD, leading sports neurologist and concussion expert at The Kutcher Clinic for Sports Neurology — in conversation with Dr. Joy Siegel, EdD, MBA.

Dr. Carpenter-Thompson will explore the evolving science of sports-related concussion, the importance of diagnostic clarity, and how objective cognitive assessment with Cognivue Clarity® can support baseline testing, post-injury evaluation, and recovery planning.

If you’re involved in sports medicine, neurology, or concussion management, you won’t want to miss this.

👉 Register here: https://bit.ly/4rcXRBj

02/05/2026

⏳ Two weeks to go, join us for an important conversation on emotional well-being and cognitive health.

Mood changes, withdrawal, anxiety, and irritability can be early indicators of cognitive change in aging adults, yet they are easy to overlook in busy clinical settings.

On February 19, join clinical neuropsychologist Dr. Ruth Morin, PhD, in conversation with Dr. Joy Siegel, EdD, MBA, for a practical discussion on how emotional well-being and cognitive health intersect—and why routine cognitive monitoring matters across care settings.

📅 February 19, 2026 | ⏰ 1:00 PM EST | 10:00 AM PST

👉 Register here:
https://bit.ly/4r6TzeD

Cognivue

01/29/2026

Highly relevant reading for anyone interested in the intersection of cognitive assessment and emerging biomarkers.

In the NeurologyLive interview “Predicting Amyloid Positivity with CARM: Clinical Insights from James Galvin, MD, MPH,” James E. Galvin, MD, MPH discusses how findings from the landmark Bio-Hermes study, sponsored by the Global Alzheimer’s Platform Foundation, informed the development of the Cognivue Amyloid Risk Measure (CARM).

CARM is designed to be interpreted alongside the overall Cognivue Clarity® cognitive assessment score, adding context to cognitive screening by helping predict the likelihood of amyloid pathology. In the interview, Dr. Galvin explains how this combined approach can support clinical decision-making and research trial screening, while fitting into existing workflows.

The article offers a practical look at how cognitive assessment and amyloid risk insights can work together to inform next steps in both clinical and research settings.

🔗 Read the full interview:
https://bit.ly/4q7IHw1

The professor of neurology at the Miami Miller School of Medicine discussed how the Cognivue Amyloid Risk Measure (CARM) may help predict amyloid presence and informs diagnosis, trial eligibility, and early treatment pathways.

01/27/2026

Sleep and Relax ( )! Insufficient sleep can not only make a person irritable, but it can also affect memory and decision making. Healthy adults need between 7 and 9 hours of sleep per night.

01/21/2026

🧠 Emotional Well-Being and the Aging Brain: What Every Provider Needs to Know

How often do early cognitive changes show up as emotional or behavioral concerns—and are we catching them soon enough?

Join clinical neuropsychologist Dr. Ruth Morin, PhD, in conversation with public health expert Dr. Joy Siegel, EdD, MBA, for a timely and practical discussion on the critical link between emotional well-being and cognitive health in aging adults.

Drawing on Dr. Morin’s extensive clinical and research experience in neuropsychology, this Cognivue webinar will explore why routine monitoring of cognitive and emotional changes is essential across healthcare settings—and how providers can integrate cognitive screening into everyday workflows without adding burden.

📅 February 19, 2026 | ⏰ 1:00 PM EST | 10:00 AM PST

👉 Register here:
https://bit.ly/4qwboUr

01/14/2026

Now live: Cognivue’s Education Page for HCP education.

We’re excited to make it easier to browse a growing set of on-demand webinars and clinical learning resources in one place. More additions to come.

Visit the learning library: https://bit.ly/49CSO5I

01/08/2026

Did you know nearly half of dementia cases may be preventable?

The 2024 Lancet Commission reports that 45% of dementia cases are potentially preventable by addressing 14 modifiable risk factors, many of which develop across early life, midlife, and later years. [1]

Cognivue is committed to supporting brain health with tools that help identify cognitive changes earlier. That is why proactive brain health matters, and why early cognitive screening can be an important step in identifying changes sooner, when intervention, planning, and support may have the greatest impact.

Let’s keep building awareness around prevention, risk reduction, and earlier insight.



Reference:
[1] Livingston G, Huntley J, Liu K, et al. (2024). Dementia Prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet. 404(10452), 572–628. DOI: 10.1016/S0140-6736(24)01296-0.

12/30/2025

As 2025 comes to a close, we reflect on a year defined by our continued commitment to advancing cognitive health.

At the heart of this work is a belief that earlier, richer cognitive insight can support more informed conversations, more personalized patient care, and clearer pathways for clinical decisions. Education plays an important role in shaping how cognitive health is understood and addressed across care settings.

Looking ahead to 2026, Cognivue remains focused on expanding awareness, continuing validation efforts and clinician education, and supporting those dedicated to improving cognitive health across diverse populations.

As shared by Cognivue's President & CEO, Paul W. Estes, “Advancing how cognitive performance is measured requires a commitment to education, evidence, and collaboration. In 2025, we made important strides in supporting earlier cognitive insight, and in 2026, we will continue building pathways that help clinicians and researchers better serve patients and communities.”

We are grateful to our partners, collaborators, and team members who contributed to this journey. We enter the new year with focus, optimism, and purpose.

12/23/2025

Maintain Connections ( )! Studies have shown that increased social activity is linked to a lower rate of cognitive decline [1]. To stay social, connect with friends and family, or consider volunteering for a local organization.



Reference: 1. James BD, Wilson RS, Barnes LL, Bennett DA. Late-life social activity and cognitive decline in old age. J Int Neuropsychol Soc. 2011 Nov;17(6):998-1005.

12/18/2025

Why does adaptive psychophysics matter in cognitive assessment?

As Dr. James E. Galvin, MD, MPH, explains in the clip below, adaptive psychophysics helps the assessment calibrate to the person taking it—setting an individual baseline and using that person as their own control. That allows the test to adjust for motor and visual differences and better isolate cognitive performance.

By keeping testing within an individual’s performance threshold, adaptive psychophysics can help reduce bias from physical or sensory limitations and support a more accurate measurement of cognitive performance.

This methodology is foundational to how Cognivue devices generate objective cognitive performance data tailored to each patient.

12/12/2025

Happy ! Today we’re celebrating the incredible people who bring Cognivue's mission to life every day. The images in this grid reflect the spirit of many of the individuals—across the field and behind the scenes—who contribute to our shared commitment to advancing cognitive health. And when it comes to our Sales team, whether they’re on the road, in clinics, supporting practices, or championing cognitive health, each person plays a vital role in bringing meaningful change to both patients and providers.

We’re also proud to celebrate a milestone this year: being named the “Top Cognitive Impairment Early Detection Company of 2025” by Healthcare Tech Outlook. This recognition reflects the hard work of our whole organization, and our sales team is a vital part of that success. Their dedication to partnering with healthcare providers, supporting clinical workflows, and expanding access to cognitive screening continues to drive our momentum and amplify the impact we’re making nationwide.

To our sales professionals: thank you for showing up with heart, resilience, and purpose. Your work strengthens our mission and helps more clinicians bring cognitive health into everyday care. Today, we honor you—and we’re excited for everything we’ll achieve together.